Harmony Biosciences Holdings (HRMY)

Operating return on assets (Operating ROA)

		Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating income	US$ in thousands	190,826	192,030	120,186	87,528	16,986
Total assets	US$ in thousands	999,200	811,448	673,870	433,443	427,074
Operating ROA		19.10%	23.67%	17.84%	20.19%	3.98%

December 31, 2024 calculation

Operating ROA = Operating income ÷ Total assets
= $190,826K ÷ $999,200K
= 19.10%

Harmony Biosciences Holdings has shown a positive trend in its operating return on assets (operating ROA) over the past five years. The operating ROA increased from 3.98% as of December 31, 2020, to 19.10% as of December 31, 2024. This indicates that the company has been able to generate more operating income relative to its assets over this period.

The operating ROA saw significant growth from 2020 to 2023, with a peak of 23.67% as of December 31, 2023. This suggests that Harmony Biosciences Holdings effectively utilized its assets to generate operating profits during that time frame.

Although there was a slight decrease in operating ROA from 2023 to 2024, it remained relatively high at 19.10%. This indicates that the company continued to efficiently utilize its assets to generate operating income even in the most recent year analyzed.

Overall, the positive trend in Harmony Biosciences Holdings' operating ROA over the five-year period reflects the company's ability to effectively manage its assets and generate operating profits, signaling a strong operational performance.